APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Biotherapeutic Products (LBP) CDMO Service

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Live Biotherapeutic Products (LBP) CDMO Service Industry Growth and Trends Forecast to 2032

5 June 2026101 pages

Choose your research edition.

Industry ResearchLive Biotherapeutic Products (LBP) CDMO Service Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Biotherapeutic Products (LBP) CDMO Service Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Live Biotherapeutic Products (LBP) CDMO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Biotherapeutic Products (LBP) CDMO Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Biotherapeutic Products (LBP) CDMO Service Market Analysis and Forecast 2026-2032251 pages · $4,950 USD

Market perspective

According to APO Research, the global Live Biotherapeutic Products (LBP) CDMO Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Live Biotherapeutic Products (LBP) CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Live Biotherapeutic Products (LBP) CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Live Biotherapeutic Products (LBP) CDMO Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Live Biotherapeutic Products (LBP) CDMO Service market include Lallemand Health Solutions, Wacker Chemie AG, Biose Industrie, List Biological Labs, Inc., NIZO, SGS (Quay Pharmaceuticals), Assembly Biosciences, Inc., Recipharm (Arranta Bio) and Bacthera (Novonesis+Lonza), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Live Biotherapeutic Products (LBP) CDMO Service market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Live Biotherapeutic Products (LBP) CDMO Service market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Live Biotherapeutic Products (LBP) CDMO Service market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Live Biotherapeutic Products (LBP) CDMO Service.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Live Biotherapeutic Products (LBP) CDMO Service market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Live Biotherapeutic Products (LBP) CDMO Service Market by Company

Lallemand Health Solutions

Wacker Chemie AG

Biose Industrie

List Biological Labs, Inc.

NIZO

SGS (Quay Pharmaceuticals)

Assembly Biosciences, Inc.

Recipharm (Arranta Bio)

Bacthera (Novonesis+Lonza)

Smaltis

Lonza

vermicon AG

Cerbios-Pharma SA

Live Biotherapeutic Products (LBP) CDMO Service Segment by Type

Solid Dosage Form

Liquid Dosage Form

Live Biotherapeutic Products (LBP) CDMO Service Segment by Application

Digestive System Diseases

Immune System Diseases

Metabolic Diseases

Other

Live Biotherapeutic Products (LBP) CDMO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Biotherapeutic Products (LBP) CDMO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Biotherapeutic Products (LBP) CDMO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Biotherapeutic Products (LBP) CDMO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Live Biotherapeutic Products (LBP) CDMO Service companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Region (2021-2026) Table 4. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Region (2027-2032) Table 6. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2026) Table 9. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Share Forecasted by Type (2027-2032) Table 11. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2026) Table 24. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Share Forecasted by Application (2027-2032) Table 26. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Live Biotherapeutic Products (LBP) CDMO Service Industry Trends Table 37. Live Biotherapeutic Products (LBP) CDMO Service Industry Drivers Table 38. Live Biotherapeutic Products (LBP) CDMO Service Industry Opportunities and Challenges Table 39. Live Biotherapeutic Products (LBP) CDMO Service Industry Restraints Table 40. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Live Biotherapeutic Products (LBP) CDMO Service Revenue Market Share by Company (2021-2026) Table 42. Global Live Biotherapeutic Products (LBP) CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Live Biotherapeutic Products (LBP) CDMO Service Key Company Headquarters & Area Served Table 44. Global Live Biotherapeutic Products (LBP) CDMO Service Company, Product Type & Application Table 45. Global Live Biotherapeutic Products (LBP) CDMO Service Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Live Biotherapeutic Products (LBP) CDMO Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Lallemand Health Solutions Company Information Table 49. Lallemand Health Solutions Business Overview Table 50. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 52. Lallemand Health Solutions Recent Development Table 53. Wacker Chemie AG Company Information Table 54. Wacker Chemie AG Business Overview Table 55. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 57. Wacker Chemie AG Recent Development Table 58. Biose Industrie Company Information Table 59. Biose Industrie Business Overview Table 60. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 62. Biose Industrie Recent Development Table 63. List Biological Labs, Inc. Company Information Table 64. List Biological Labs, Inc. Business Overview Table 65. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 67. List Biological Labs, Inc. Recent Development Table 68. NIZO Company Information Table 69. NIZO Business Overview Table 70. NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 72. NIZO Recent Development Table 73. SGS (Quay Pharmaceuticals) Company Information Table 74. SGS (Quay Pharmaceuticals) Business Overview Table 75. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 77. SGS (Quay Pharmaceuticals) Recent Development Table 78. Assembly Biosciences, Inc. Company Information Table 79. Assembly Biosciences, Inc. Business Overview Table 80. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 82. Assembly Biosciences, Inc. Recent Development Table 83. Recipharm (Arranta Bio) Company Information Table 84. Recipharm (Arranta Bio) Business Overview Table 85. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 87. Recipharm (Arranta Bio) Recent Development Table 88. Bacthera (Novonesis+Lonza) Company Information Table 89. Bacthera (Novonesis+Lonza) Business Overview Table 90. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 92. Bacthera (Novonesis+Lonza) Recent Development Table 93. Smaltis Company Information Table 94. Smaltis Business Overview Table 95. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 97. Smaltis Recent Development Table 98. Lonza Company Information Table 99. Lonza Business Overview Table 100. Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 102. Lonza Recent Development Table 103. vermicon AG Company Information Table 104. vermicon AG Business Overview Table 105. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 107. vermicon AG Recent Development Table 108. Cerbios-Pharma SA Company Information Table 109. Cerbios-Pharma SA Business Overview Table 110. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio Table 112. Cerbios-Pharma SA Recent Development Table 113. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 115. North America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2026) Table 116. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. North America Live Biotherapeutic Products (LBP) CDMO Service Market Share Forecast by Country (2027-2032) Table 118. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 120. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2026) Table 121. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Share Forecast by Country (2027-2032) Table 123. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 125. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2026) Table 126. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Share Forecast by Country (2027-2032) Table 128. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 130. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2026) Table 131. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Share Forecast by Country (2027-2032) Table 133. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026) & (US$ Million) Table 135. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2026) Table 136. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Share Forecast by Country (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Live Biotherapeutic Products (LBP) CDMO Service Product Image Figure 3. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size (2021-2032) & (US$ Million) Figure 5. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Region: 2025 VS 2032 Figure 6. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Region (2021-2032) Figure 7. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Solid Dosage Form Image Figure 13. Global Solid Dosage Form Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Liquid Dosage Form Image Figure 15. Global Liquid Dosage Form Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Type 2025 VS 2032 Figure 18. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2032) Figure 19. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2032) Figure 21. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Type (2021-2032) Figure 23. Digestive System Diseases Image Figure 24. Global Digestive System Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Immune System Diseases Image Figure 26. Global Immune System Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Metabolic Diseases Image Figure 28. Global Metabolic Diseases Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Other Image Figure 30. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Live Biotherapeutic Products (LBP) CDMO Service Market Share by Application 2025 VS 2032 Figure 33. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2032) Figure 34. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2032) Figure 35. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2032) Figure 36. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2032) Figure 37. Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Share by Application (2021-2032) Figure 38. Global Top 5 and 10 Live Biotherapeutic Products (LBP) CDMO Service Players Market Share by Revenue in 2025 Figure 39. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 40. North America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 41. North America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 42. North America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2032) Figure 43. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2032) Figure 46. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 47. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 48. Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2032) Figure 49. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2032) Figure 52. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Share by Country (2021-2032) Figure 55. Years Considered Figure 56. Research Process Figure 57. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Dosage Form
  • Liquid Dosage Form
Applications
  • Digestive System Diseases
  • Immune System Diseases
  • Metabolic Diseases
  • Other
Companies covered
  • Lallemand Health Solutions
  • Wacker Chemie AG
  • Biose Industrie
  • List Biological Labs, Inc.
  • NIZO
  • SGS (Quay Pharmaceuticals)
  • Assembly Biosciences, Inc.
  • Recipharm (Arranta Bio)
  • Bacthera (Novonesis+Lonza)
  • Smaltis
  • Lonza
  • vermicon AG
  • Cerbios-Pharma SA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2032)
  5. 1.4.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2021-2026)
  6. 1.4.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Region (2027-2032)
  7. 1.5 Key Regions Live Biotherapeutic Products (LBP) CDMO Service Market Size (2021-2032)
  8. 1.5.1 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (2021-2032)
2 Live Biotherapeutic Products (LBP) CDMO Service Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Solid Dosage Form
  3. 2.1.2 Liquid Dosage Form
  4. 2.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Type
  5. 2.2.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Live Biotherapeutic Products (LBP) CDMO Service Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Regions
  9. 2.3.1 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Type (2021-2026)
3 Live Biotherapeutic Products (LBP) CDMO Service Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Digestive System Diseases
  3. 3.1.2 Immune System Diseases
  4. 3.1.3 Metabolic Diseases
  5. 3.1.4 Other
  6. 3.2 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Application
  7. 3.2.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Live Biotherapeutic Products (LBP) CDMO Service Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Live Biotherapeutic Products (LBP) CDMO Service Market Size by Regions
  11. 3.3.1 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Live Biotherapeutic Products (LBP) CDMO Service Industry Trends
  2. 4.2 Live Biotherapeutic Products (LBP) CDMO Service Industry Drivers
  3. 4.3 Live Biotherapeutic Products (LBP) CDMO Service Industry Opportunities and Challenges
  4. 4.4 Live Biotherapeutic Products (LBP) CDMO Service Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Live Biotherapeutic Products (LBP) CDMO Service Revenue (2021-2026)
  2. 5.2 Global Live Biotherapeutic Products (LBP) CDMO Service Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Live Biotherapeutic Products (LBP) CDMO Service Key Company Headquarters & Area Served
  4. 5.4 Global Live Biotherapeutic Products (LBP) CDMO Service Company, Product Type & Application
  5. 5.5 Global Live Biotherapeutic Products (LBP) CDMO Service Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Live Biotherapeutic Products (LBP) CDMO Service Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Live Biotherapeutic Products (LBP) CDMO Service Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Live Biotherapeutic Products (LBP) CDMO Service Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Lallemand Health Solutions
  2. 6.1.1 Lallemand Health Solutions Company Information
  3. 6.1.2 Lallemand Health Solutions Business Overview
  4. 6.1.3 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Lallemand Health Solutions Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  6. 6.1.5 Lallemand Health Solutions Recent Developments
  7. 6.2 Wacker Chemie AG
  8. 6.2.1 Wacker Chemie AG Company Information
  9. 6.2.2 Wacker Chemie AG Business Overview
  10. 6.2.3 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Wacker Chemie AG Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  12. 6.2.5 Wacker Chemie AG Recent Developments
  13. 6.3 Biose Industrie
  14. 6.3.1 Biose Industrie Company Information
  15. 6.3.2 Biose Industrie Business Overview
  16. 6.3.3 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Biose Industrie Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  18. 6.3.5 Biose Industrie Recent Developments
  19. 6.4 List Biological Labs, Inc.
  20. 6.4.1 List Biological Labs, Inc. Company Information
  21. 6.4.2 List Biological Labs, Inc. Business Overview
  22. 6.4.3 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 List Biological Labs, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  24. 6.4.5 List Biological Labs, Inc. Recent Developments
  25. 6.5 NIZO
  26. 6.5.1 NIZO Company Information
  27. 6.5.2 NIZO Business Overview
  28. 6.5.3 NIZO Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 NIZO Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  30. 6.5.5 NIZO Recent Developments
  31. 6.6 SGS (Quay Pharmaceuticals)
  32. 6.6.1 SGS (Quay Pharmaceuticals) Company Information
  33. 6.6.2 SGS (Quay Pharmaceuticals) Business Overview
  34. 6.6.3 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 SGS (Quay Pharmaceuticals) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  36. 6.6.5 SGS (Quay Pharmaceuticals) Recent Developments
  37. 6.7 Assembly Biosciences, Inc.
  38. 6.7.1 Assembly Biosciences, Inc. Company Information
  39. 6.7.2 Assembly Biosciences, Inc. Business Overview
  40. 6.7.3 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Assembly Biosciences, Inc. Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  42. 6.7.5 Assembly Biosciences, Inc. Recent Developments
  43. 6.8 Recipharm (Arranta Bio)
  44. 6.8.1 Recipharm (Arranta Bio) Company Information
  45. 6.8.2 Recipharm (Arranta Bio) Business Overview
  46. 6.8.3 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Recipharm (Arranta Bio) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  48. 6.8.5 Recipharm (Arranta Bio) Recent Developments
  49. 6.9 Bacthera (Novonesis+Lonza)
  50. 6.9.1 Bacthera (Novonesis+Lonza) Company Information
  51. 6.9.2 Bacthera (Novonesis+Lonza) Business Overview
  52. 6.9.3 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Bacthera (Novonesis+Lonza) Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  54. 6.9.5 Bacthera (Novonesis+Lonza) Recent Developments
  55. 6.10 Smaltis
  56. 6.10.1 Smaltis Company Information
  57. 6.10.2 Smaltis Business Overview
  58. 6.10.3 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Smaltis Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  60. 6.10.5 Smaltis Recent Developments
  61. 6.11 Lonza
  62. 6.11.1 Lonza Company Information
  63. 6.11.2 Lonza Business Overview
  64. 6.11.3 Lonza Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Lonza Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  66. 6.11.5 Lonza Recent Developments
  67. 6.12 vermicon AG
  68. 6.12.1 vermicon AG Company Information
  69. 6.12.2 vermicon AG Business Overview
  70. 6.12.3 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 vermicon AG Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  72. 6.12.5 vermicon AG Recent Developments
  73. 6.13 Cerbios-Pharma SA
  74. 6.13.1 Cerbios-Pharma SA Company Information
  75. 6.13.2 Cerbios-Pharma SA Business Overview
  76. 6.13.3 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Cerbios-Pharma SA Live Biotherapeutic Products (LBP) CDMO Service Product Portfolio
  78. 6.13.5 Cerbios-Pharma SA Recent Developments
7 North America
  1. 7.1 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
  3. 7.3 North America Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
  3. 8.3 Europe Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
  3. 10.3 South America Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Live Biotherapeutic Products (LBP) CDMO Service Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst